Changes

no edit summary
Line 1,693: Line 1,693:  
|-
 
|-
 
|[[HAEM5:Diffuse large B-cell lymphoma, NOS|Diffuse large B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| ||
 
|[[HAEM5:Diffuse large B-cell lymphoma, NOS|Diffuse large B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| ||
|
+
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified
 
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
 
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
 +
|Pending
 
|
 
|
|
+
|Requested to update 14022022
|
   
|-
 
|-
 
|[[HAEM5:T-cell/histiocyte-rich large B-cell lymphoma|T-cell/histiocyte-rich large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||
 
|[[HAEM5:T-cell/histiocyte-rich large B-cell lymphoma|T-cell/histiocyte-rich large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||